Infographic: Optimizing freeze/thaw for gene therapy production: Batch drug substance solution

Gene therapies offer a promising approach to treating cancers and rare diseases. Freeze/thaw processes, such as lyophilization (freeze-drying), play a vital role in the development of these therapies by preserving their stability and quality during production and storage.
Owing to recent advancements in the gene therapy space, it is becoming increasingly important that the manufacturing processes underpinning these life-saving therapies are optimized, to ensure patients in need receive timely access to treatment.
Within this infographic, we explore the importance of freeze/thaw processes for bulk drug substance in gene therapy production. This details how Symbiosis’ integrated gene therapy offering can support you in optimizing your freeze/thaw process, to ultimately benefit your gene therapy manufacturing process.